258 related articles for article (PubMed ID: 26398776)
1. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
[TBL] [Abstract][Full Text] [Related]
2. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
Baglieri J; Brenner DA; Kisseleva T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
[TBL] [Abstract][Full Text] [Related]
3. Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer-Associated Fibroblasts Formed After Chronic Liver Injuries.
Wang SS; Tang XT; Lin M; Yuan J; Peng YJ; Yin X; Shang G; Ge G; Ren Z; Zhou BO
Hepatology; 2021 Sep; 74(3):1578-1594. PubMed ID: 33817801
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts in hepatocellular carcinoma.
Kubo N; Araki K; Kuwano H; Shirabe K
World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acids and hepatic stellate cells in liver disease.
Lee YS; Jeong WI
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():75-9. PubMed ID: 22320921
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrogenic cells.
Forbes SJ; Parola M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):207-17. PubMed ID: 21497739
[TBL] [Abstract][Full Text] [Related]
9. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma.
Yavuz BG; Pestana RC; Abugabal YI; Krishnan S; Chen J; Hassan MM; Wolff RA; Rashid A; Amin HM; Kaseb AO
Oncotarget; 2020 Mar; 11(13):1186-1201. PubMed ID: 32284794
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
11. Friend or foe? The elusive role of hepatic stellate cells in liver cancer.
Cogliati B; Yashaswini CN; Wang S; Sia D; Friedman SL
Nat Rev Gastroenterol Hepatol; 2023 Oct; 20(10):647-661. PubMed ID: 37550577
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.
Affo S; Yu LX; Schwabe RF
Annu Rev Pathol; 2017 Jan; 12():153-186. PubMed ID: 27959632
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
15. CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.
Liu Z; Chen M; Zhao R; Huang Y; Liu F; Li B; Qin Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):18-25. PubMed ID: 31828297
[TBL] [Abstract][Full Text] [Related]
16. Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury.
Lua I; James D; Wang J; Wang KS; Asahina K
Hepatology; 2014 Jul; 60(1):311-22. PubMed ID: 24488807
[TBL] [Abstract][Full Text] [Related]
17. Roles for chemokines in liver disease.
Marra F; Tacke F
Gastroenterology; 2014 Sep; 147(3):577-594.e1. PubMed ID: 25066692
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis.
Ezhilarasan D
J Cell Physiol; 2022 Jan; 237(1):436-449. PubMed ID: 34514599
[TBL] [Abstract][Full Text] [Related]
20. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
Schmitt-Graeff A; Jing R; Nitschke R; Desmoulière A; Skalli O
Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
